Corporate News 21-Jul-22
Biocon concludes USFDA pre-approval inspection of its site in Hyderabad
Biocon announced that USFDA concluded a pre-approval inspection for Site 3, Biocon, located at Hyderabad, Telangana on 20 July 2022. Three observations were cited at the end of the Inspection.
Previous News
Biocon Ltd rises for third consecutive session
( Hot Pursuit - 24-Apr-24 13:05 )
Biocon Ltd soars 2.25%, up for fifth straight session
( Hot Pursuit - 11-Jun-24 13:00 )
Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
( Hot Pursuit - 24-Jun-24 09:34 )
Biocon Ltd soars 1.22%, rises for fifth straight session
( Hot Pursuit - 27-Mar-24 13:00 )
Board of Biocon appoints director
( Corporate News - 27-Jul-23 12:46 )
Biocon announces resignation of senior management
( Corporate News - 08-Feb-24 19:49 )
Indices edge lower, Nifty near 18,300; breadth positive
( Market Commentary - Mid-Session 24-May-23 09:32 )
Biocon slips after CFO resigns
( Hot Pursuit - 15-Mar-24 11:08 )
Biocon to conduct board meeting
( Corporate News - 22-Jul-23 10:58 )
Biocon Biologics appoints Shreehas Tambe as MD, CEO
( Hot Pursuit - 05-Dec-22 15:07 )
Biocon signs distribution and supply agreement with Medix
( Corporate News - 13-May-24 09:36 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
